ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

フィダキソマイシン

FidaxoMicin

HCID 46174142
ノート反応

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
873857-62-6
標準SMILES
CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C\[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C
分子式
C52H74Cl2O18
平均分子量
1,058.04 g/mol

名称と識別子

優先名称
FidaxoMicin
現地名
フィダキソマイシン
英語名
FidaxoMicin
分子式
C52H74Cl2O18
分子量
1058.04

名称と別名

フィダキソマイシンフィダキソマイシン (JAN)(8S,11S,12R,18S)-3-[[4-O-(3,5-ジクロロ-2-エチル-4,6-ジヒドロキシベンゾイル)-2-O-メチル-6-デオキシ-β-D-マンノピラノシル]オキシメチル]-12-[[4-O-(2-メチルプロパノイル)-5-メチル-6-デオキシ-β-D-マンノピラノシル]オキシ]-11-エチル-18-[(R)-1-ヒドロキシエチル]-8-ヒドロキシ-9,13,15-トリメチルオキサシクロオクタデカ-3,5,9,13,15-ペンタエン-2-オンリピアルマイシンA3(2R,3S,4S,5S,6R)-6-{[(8S,11S,12R,18S)-12-{[(2R,3S,4R,5S)-3,4-ジヒドロキシ-6,6-ジメチル-5-[(2-メチルプロパノイル)オキシ]オキサン-2-イル]オキシ}-11-エチル-8-ヒドロキシ-18-[(1R)-1-ヒドロキシエチル]-9,13,15-トリメチル-2-オキソ-1-オキサシクロオクタデカ-3,5,9,13,15-ペンタエン-3-イル]メトキシ}-4-ヒドロキシ-5-メトキシ-2-メチルオキサン-3-イル 3,5-ジクロロ-2-エチル-4,6-ジヒドロキシベンゾアートチアクマイシンBFidaxomicin CrystallineDificidFidaxomycinFidaxoMicinrUS-DMF No.: 028803FidaxoMicin USP/EP/BP
名称をさらに表示
OPT-80PAR-101CLOSTOMICIN B1TIACUMICIN B3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-eth3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-ethyl-8(S)-hydro

物性

物理化学的性質

融点
161 °C · 161 °C
沸点
1046.4 · 1046.4±65.0 °C(Predicted)
比重(密度)
1.33 · 1.33
貯蔵温度
2 · 2-8°C
溶解性
クロロホルム(微量、加熱)、DMSO(微量、加熱)、メタノール(微量)
外見
粉
酸解離定数(Pka)
5.09 · 5.09±0.35(Predicted)
色
ホワイトからオフホワイト
由来生物
(Actinoplanes deccanensis)
InChIKey
HRDFANQMSCFNSU-KLTYAODHNA-N

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
WGK 3
hs_code
2941900000
ストレージクラス
11 - Combustible Solids

化学と産業

応用分野 · 2 件

説明Fidaxomicin (OPT-80) was approved by the U.S. FDA in May 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD), joining metronidazole and vancomycin as drugs recommended for treatment of C. difficile infections (CDI). Fidaxomicin, also known as lipiarmycin and tiacumicin, is an 18-membered macrolide natural product that was first reported in mid-1970s and is produced by fermentation. Fidaxomicin and its primary metabolite OP-1118, which results from hydrolysis of the isobutyryl ester, are narrowspectrum antibacterial agents with activity against gram-positive aerobic and anaerobic organisms, but not against gram-negative organisms. Fidaxomicin and OP-1118 exert their antibacterial activity by inhibiting bacterial RNA polymerase, thereby inhibiting bacterial protein synthesis. The MIC90 (minimum inhibitory concentration to kill 90% of bacteria) for fidaxomicin against C.difficile is 0.125–0.25 μg/mL; OP- 1118 is 4- to 16-fold less potent than the parent compound. Fidaxomicin has been reported to spare native intestinal flora such as Bacteroides spp. and as such, may prevent selection of drug-resistant bacteria. Fidaxomicin is bactericidal to C. difficile and has a low propensity for resistance development with no cross-resistance to existing antibiotics. Fidaxomicin shows minimal systemic absorption following oral administration in preclinical studies and humans.

使用Fidaxomicin is a recently marketed antibiotic with a confusing history dating back to its original isolation in 1975. Fidaxomicin is the major analogue of a family of macrocyclic lactones, isolated independently by three different groups from cultures belonging to three different genera (Actinoplanes, Dactylosporangium and Micromonospora) known as lipiarmycin A3, tiacumicin B and clostomicin B1, respectively. Fidaxomicin is a narrow spectrum antibiotic with excellent activity against Gram positive bacteria, notably Clostridium difficile. Fidaxomicin acts in the gastrointestinal tract without undue disruption to gut microbial flora.

サプライヤー100 社

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl)oxy]-11(S)-ethyl-8(S)-hydroxy-18(S)-(1(R)-hydroxy

データベース識別子

CAS
873857-62-6
PubChem CID
46174142
广州隽沐生物科技股份有限公司
020-36607679; 13502246435 · [email protected]
河北展药生物科技有限公司15369953316 +8615369953316 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
上海波以尔化工有限公司[email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
博瑞生物医药(苏州)股份有限公司0512-0512-62551764 18013103761 · [email protected]
上海柯维化学技术有限公司021-64609169 18901607656 · [email protected]
武汉瑞立升科技发展有限公司27-027-83314682 13554138826 · [email protected]
上海泰坦科技股份有限公司4006009262 13023226327 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
上海瀚香生物科技有限公司177-54423994 17754423994 · [email protected]
上海汉景化工有限公司021-54285032 13641685631 · [email protected]
湖南汇百侍生物科技有限公司0731-85526065 13308475853 · [email protected]
深圳菲斯生物科技有限公司0755-83725681-603
南京爱莉生物科技有限公司025-83208295 18913388297 · [email protected]
AdooQ BioScience, LLC+1 (866) 930-6790 · [email protected]
杭州中美华东制药江东有限公司0571-82907203 15606520558 · [email protected]
上海遐瑞医药科技有限公司+86 21 61551611
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Shanghai Witofly Chemical Co.,Ltd[email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
湖北威德利化学试剂有限公司186-02735115 18602735115 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
上海将来实业股份有限公司021-61552785 · [email protected]
上海石洋化工有限公司021-56795766 · [email protected]
广州致雅医药科技有限公司18122150900 · [email protected]
杭州杰恒化工有限公司0571-87396432 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
台州市科德化工有限公司0576-84613060 13093829633;13736603231 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
Sigma-Aldrich西格玛奥德里奇(上海)贸易有限公司021-61415566 800-8193336 · [email protected]
上海泽涵生物医药科技有限公司021-61350663 13052117465 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海昕凯医药科技有限公司21-619849051-1 18521059765 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
杭州鼎燕化工有限公司0571-87157530-8003 18049756717 · [email protected]
西安天广源生物科技有限公司+86-029-86333380 +86-18829239519 · [email protected]
Qiuxian Baitai New Material Co., LTD+86-19932103556 · [email protected]
武汉柏森源生物科技有限公司027-51335350 15107175693 · [email protected]
药渡经纬信息科技(北京)有限公司+86-400-851-9921 · [email protected]
上海思言生物科技有限公司021-50908862,442785678,326799392 18721037013 · [email protected]
广州市齐云生物技术有限公司020-61288194 61288195 · [email protected]

補足説明

定義ChEBI: An 18-membered macrolide that is a fermentation product obtained from the Actinomycete Dactylosporangium aurantiacum. A narrow spectrum antibiotic used for treatment of Clostridium difficile-related infections.